<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[IVAX Corp. | Company News & Executive Profiles - IVX | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ivax+corp..html]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for IVAX Corp.]]></description>
	<s:counts start="0" returned="10" found="548" />
	<language>en-us</language>
	<item>
		<title><![CDATA[United States Department of Justice - the J&J connection]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/united-states-department-justice-connection/18994/]]></link>
		<description><![CDATA[    WASHINGTON — The nation's largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million, and drug manufacturer, IVAX Pharmaceuticals of Weston, Florida, will pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties, including IVAX, the Justice Department...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 13:23:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mariner+health+care.html"><![CDATA[Mariner Health Care]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Omnicare settles drug kickbacks probe]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/news-analysis/omnicare-settles-drug-kickbacks-probe/18938/]]></link>
		<description><![CDATA[Another day, another drug-marketing settlement. Omnicare, which provides pharmacy services to nursing homes, agreed to pay $98 million to settle allegations that it accepted and asked for kickbacks, the U.S. Justice Department announced. And Teva Pharmaceutical Industries subsidiary IVAX will pay $14 million on claims that it forked over $8...]]></description>
		<s:doctype><![CDATA[News items]]></s:doctype>
		<pubDate>Wed, 04 Nov 2009 09:22:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[company]]></category>
		<category domain="http://resources.bnet.com/topic/home.html"><![CDATA[home]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[Settlement]]></category>
		<category domain="http://resources.bnet.com/topic/wall+street+journal.html"><![CDATA[Wall Street Journal]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+department+of+justice.html"><![CDATA[U.S. Department Of Justice]]></category>
		<category domain="http://resources.bnet.com/topic/allegation.html"><![CDATA[allegation]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="tickers">IVX,JNJ</category>
	</item>
	<item>
		<title><![CDATA[Depomed Settles Patent Litigation Against IVAX]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_7/ai_n25129250]]></link>
		<description><![CDATA[Depomed to Receive $10 Million in Settlement and Royalties]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 07 Apr 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/patent+litigation.html"><![CDATA[patent litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Diagnostics Announces Resignation of President and Chief Executive Officer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_Jan_3/ai_n27488306]]></link>
		<description><![CDATA[MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) announced today that, after 27 years of distinguished service on behalf the Company and its subsidiaries, Giorgio D'Urso is resigning as President and Chief Executive Officer of the Company and as a member of the Board of Directors of the Company, effective January 10,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 03 Jan 2008 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Court Grants Depomed's Motion for Summary Judgment of Patent Infringement Against IVAX]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_13/ai_n27474039]]></link>
		<description><![CDATA[Court Rejects All Summary Judgment Motions From IVAX]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Dec 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/summary+judgment.html"><![CDATA[Summary Judgment]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Diagnostics Reports Third Quarter Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_14/ai_n27446431]]></link>
		<description><![CDATA[MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) reported net revenues for the third quarter of 2007 of $4,972,000, a 2.5% increase over net revenues of $4,852,000 for the same period of 2006. IVAX Diagnostics reported a net loss of $7,841,000 for the third quarter of 2007 compared to a net loss...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 14 Nov 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Diagnostics Appoints Kevin D. Clark Chief Operating Officer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Sept_20/ai_n27381615]]></link>
		<description><![CDATA[MIAMI -- IVAX Diagnostics, Inc. (AMEX:IVD) announced today that, effective September 17, 2007, Kevin D. Clark has been appointed Chief Operating Officer of IVAX Diagnostics. In addition to serving as Chief Operating Officer of IVAX Diagnostics, Mr. Clark will continue to serve as Chief Operating Officer of ImmunoVision, Inc., IVAX...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 20 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Diagnostics Reports Second Quarter Results]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_August_10/ai_n19448817]]></link>
		<description><![CDATA[Provides Update on the Status of the Development of the PARSEC[R] System]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 10 Aug 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Teva is The Clear Market Leader Since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs In The UK 2007.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200707/ai_n19769415]]></link>
		<description><![CDATA[M2 PRESSWIRE-2 July 2007-Research and Markets: Teva is The Clear  Market Leader Since Its 2006 Purchase of IVAX States New Report  Opportunities and Challenges for Generic Drugs In The UK  2007C1994-2007 M2 COMMUNICATIONS LTD    RDATE:04072007    Dublin - Research and Markets ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jul 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/clear.html"><![CDATA[Clear]]></category>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[leader]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/prescription.html"><![CDATA[prescription]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/u.k..html"><![CDATA[U.K.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Research and Markets: Teva is The Clear Market Leader since Its 2006 Purchase of IVAX States New Report Opportunities and Challenges for Generic Drugs in the UK 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_July_2/ai_n19330374]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c61363) has announced the addition of Espicom Business Intelligence report Opportunities and Challenges for Generic Drugs in the UK 2007 to their offering.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 Jul 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/clear.html"><![CDATA[Clear]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/leader.html"><![CDATA[leader]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
